This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.Hyperphosphatemia is increasingly linked with cardiovascular disease (CVD) in patients with chronic kidney disease (CKD). 25-hydroxyvitamin D3 (25D) deficiency has also been increasingly linked to CVD. To further explore the degree to which hyperphosphatemia and 25D deficiency impact CVD in patients with CKD, we will test whether phosphorus restriction using oral phosphorus binders and treatment of vitamin D deficiency can improve non-invasive measures of CVD in subjects with CKD.
Showing the most recent 10 out of 945 publications